Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd._鞍石生物科技是中国创新药企业,旗下拥有两个全资子公司:北京浦润奥生物科技有限责任公司成立于2012年;北京鞍石生物科技有限责任公司成立于2018年。
鞍石生物科技致力于健康服务产业,以为患者提供高质量医药产品作为宗旨。专注于抗肿瘤创新药物的研发,拥有多个药物研发管线,主要研发方向为肿瘤治疗领域”First In Class”及“Best In Class”的创新药物,涵盖肺癌、脑胶质瘤等多个肿瘤治疗领域。
鞍石生物科技始终致力于:通过提供高品质创新药物,让患者生活更有质量,用持续创新为人类健康服务。通过完整
Investors 1
Date | Name | Website |
11.02.2024 | Vivo Capit... | vivocapita... |
Mentions in press and media 3
Date | Title | Description | Source |
04.01.2024 | Avistone Biotechnology Closes Series B Funding | Avistone Biotechnology, a Beijing, China-based biotechnology company focused on precision oncology t... | finsmes.co... |
28.12.2023 | Deals in brief: OpenAI seeks fresh funding at valuation nort... | OpenAI is seeking funding at valuation north of USD 100 billion With the dust settling on the leader... | kr-asia.co... |
- | Avistone Pharmaceuticals | “Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.” | fastfounde... |